MedTrace Logo

Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment

NCT05648955 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2023-07-28

No results posted yet for this study

Summary

Malnutrition and low muscle mass (sarcopenia) are common problems in patients with cancer. However, a low muscle mass is associated with negative clinical outcomes in patients with cancer. Therefore, it is very important to maintain muscle mass in this population. This study aims to investigate the effect of an oral nutritional supplement on skeletal muscle mass during anti-cancer treatment.

Conditions

  • Colorectal Cancer (CRC)
  • Non-small Cell Lung Cancer (NSCLC)

Interventions

DIETARY_SUPPLEMENT

an enriched high protein and high energy oral nutrition supplement (ONS)

NA (see intervention name)

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05648955 on ClinicalTrials.gov